बीटा
ट्रायल रडार AI
क्लिनिकल ट्रायल NCT05817305 (ITER) के लिए हृदयवाहिनी रोगों, शारीरिक निष्क्रियता, बुढ़ापा, जीवन की गुणवत्ता, चिकित्सक-रोगी संबंध वर्तमान में भर्ती जारी है। सभी विवरणों के लिए क्लिनिकल ट्रायल रडार कार्ड दृश्य और AI खोज उपकरण देखें, या यहाँ कुछ भी पूछें।
एक परीक्षण फ़िल्टर मानदंडों से मेल खाता है
कार्ड दृश्य

Integrating Exercise Into Lifestyle of Cardiac Outpatients (ITER)

भर्ती जारी
चिकित्सा परीक्षण का विवरण मुख्य रूप से अंग्रेजी में उपलब्ध है। हालाँकि, ट्रायल रडार AI मदद कर सकता है! बस 'परीक्षण समझाएं' पर क्लिक करें और अपनी चुनी हुई भाषा में परीक्षण की जानकारी देखें और चर्चा करें।
क्लिनिकल परीक्षण NCT05817305 (ITER) एक प्रेक्षणीय चिकित्सकीय अध्ययन है जो हृदयवाहिनी रोगों, शारीरिक निष्क्रियता, बुढ़ापा, जीवन की गुणवत्ता, चिकित्सक-रोगी संबंध से जुड़ा हुआ है। परीक्षण वर्तमान में भर्ती जारी चल रहा है। इसकी शुरुआत 1 जनवरी 1997 को हुई थी, और इसमें कुल 5,000 प्रतिभागियों के नामांकन की योजना है। Università degli Studi di Ferrara इस परीक्षण का नेतृत्व कर रहे हैं और इसके 31 दिसंबर 2047 तक पूरा होने की उम्मीद है। ClinicalTrials.gov वेबसाइट पर यह जानकारी 10 अप्रैल 2025 को अंतिम बार अपडेट की गई थी
संक्षिप्त सारांश
The purpose of the study is to investigate the long-term effects of a personalized physical activity program on exercise capacity and quality of life in patients with stable cardiovascular disease. The analysis also intends to evaluate the prognostic value of cardiovascular function estimated through a walking test (1km Treadmill Walking Test, 1k-TWT) in relation to survival, hospitalization, and medical costs. The program considers clinical, socio-economic, and behavioural aspects, psychological support, and risk factor control. Patients receive indications for carrying out a home training program based on the performance of moderate-intensity aerobic activity at least 3-4 days a week for at least 30-60 minutes a day. All patients are also encouraged to improve their daily habits by preferring a more active lifestyle both at home and at work.
विस्तृत विवरण
BACKGROUND: Physical activity and cardiorespiratory fitness are considered major markers of cardiovascular risk and core components of secondary prevention programs for cardiovascular diseases (CVD). The benefits of regular physical activity are well-recognized both for men and women and are inversely associated with mortality risk and the incidence of many chronic diseases. Despite the efforts of many health organizations to increase awareness of this evidence, physical inactivity and low cardiorespiratory fitness remain overlooked risk factors. Directly measured peak oxygen consumption (VO2peak) determined during maximal incremental cardiopulmonary exercise testing (CPX) is the gold standard objective measure of cardiorespiratory fitness. However, because of physical, financial, and time limitations, a direct determination is often not routinely assessed in clinical settings. Submaximal exercise testing can be a viable alternative to CPX. These tests are more practical for examining older adults or a large patient cohort. Also, they are helpful in defining functional limitations, setting up appropriate physical activity programs, and assessing the outcomes of pharmacological treatments.

RATIONALE AND OBJECTIVE OF THE STUDY: The benefits of regular physical activity are well-recognized both for men and women and are inversely associated with mortality risk and the incidence of many chronic diseases. The purpose of this observational registry is to evaluate the efficacy of an exercise-based secondary prevention program among male and female outpatients with stable cardiovascular disease.

DESCRIPTION OF THE FUNCTIONAL EVALUATION: During each session, information about weight, height, body mass index (BMI), blood pressure, cardiometabolic risk factors, and drug therapy in progress are registered. Physical activity habits are assessed using the Seven-Day Physical Activity Recall questionnaire. In addition, patients complete a sub-maximal test of 1km treadmill walking (1k-TWT), which is performed at a moderate intensity and adjusted according to the patient's perception of fatigue. Patients unable to complete the test at a walking speed ≥ 3.0 km/h can perform the test over 500m or 200m. Based on the results of the test, patients receive indications for the proper execution of a home training program, (i.e., at the same effort perceived in the test). The activity should be done at least 3-4 times per week, preferably every day, for at least 30-60 minutes. All patients are also encouraged to improve their daily habits by opting for a more active lifestyle at home and at work. Written informed consent is required from all participants at the time of enrollment.

आधिकारिक शीर्षक

Efficacy of an Exercise-based Secondary Prevention Program in Patients With Stable Cardiovascular Disease

चिकित्सीय स्थितियाँ
हृदयवाहिनी रोगोंशारीरिक निष्क्रियताबुढ़ापाजीवन की गुणवत्ताचिकित्सक-रोगी संबंध
प्रकाशन
इस नैदानिक परीक्षण के बारे में प्रकाशित वैज्ञानिक लेख और शोध पत्र:
और दिखाएँ
अन्य अध्ययन आईडी
  • ITER
  • CSB-21-01
NCT नंबर
अध्ययन प्रारंभ तिथि (वास्तविक)
1997-01-01
अंतिम अद्यतन प्रकाशित
2025-04-10
अध्ययन की समाप्ति तिथि (अनुमानित)
2047-12-31
नामांकन (अनुमानित)
5,000
अध्ययन प्रकार
प्रेक्षणीय
स्थिति
भर्ती जारी
प्रमुख शब्द
Cardiovascular disease
Physical activity
Epidemiology
Cardiorespiratory fitness
समूह/हस्तक्षेप
प्रतिभागी समूह/हाथहस्तक्षेप/इलाज
Cardiac outpatients
Patients with stable cardiovascular disease who have been referred to the service by their general practitioner or cardiologist
Medical History and Functional Evaluation
During each session, physical parameters are measured and data on medical history and physical activity are collected. To assess cardiorespiratory fitness, all patients complete a submaximal, moderate, and perceptually regulated treadmill walking test (1k-TWT). Patients unable to complete the test at a walking speed ≥ 3.0 km/h perform the test over 500m or 200m.
स्वास्थ्य शिक्षा
Patients receive recommendations for risk factor management as well as continuous motivational counselling in order to develop and maintain a stable active lifestyle.
प्राथमिक परिणाम माप
परिणाम मापमाप विवरणसमय सीमा
Mortality
Association of all-cause mortality and cause-specific death with exercise capacity
From date of enrollment until the date of end of follow-up or date of death from any cause, whichever came first, assessed up to 12 years
द्वितीयक परिणाम माप
परिणाम मापमाप विवरणसमय सीमा
Hospitalization
Association of cause-specific hospitalization with exercise capacity
From date of enrollment until the first hospitalization (any hospital admission is considered an event), assessed up to 12 years
Peak Oxygen Uptake (VO2peak)
Measurement of cardiorespiratory fitness, reported as ml/kg/min and estimated through a moderate and perceptually regulated 1km treadmill walk test (1k-TWT) or through related short-forms (500m or 200m)
From date of enrollment until the date of end of follow-up or date of death from any cause, whichever came first, assessed up to 12 years
Leisure time physical activity levels
Measurement of physical activity levels, reported as MET/h-week and estimated through the 7-day physical activity recall questionnaire
From date of enrollment until the date of end of follow-up or date of death from any cause, whichever came first, assessed up to 12 years
पात्रता मानदंड

अध्ययन के लिए पात्र आयु
वयस्क, वृद्ध वयस्क
अध्ययन के लिए न्यूनतम आयु
18 Years
अध्ययन के लिए पात्र लिंग
सभी
स्वस्थ स्वयंसेवकों को स्वीकार करता है
हाँ
  • the presence of one or more previous cardiovascular events

  • Ejection fraction < 30%
  • Chronic heart failure NYHA III-IV
  • Severe aortic or mitral valvulopathy
  • Severe physical or cognitive impairment
  • Exercise-induced complex arrhythmias
Università degli Studi di Ferrara logoUniversità degli Studi di Ferrara
अध्ययन उत्तरदायी पक्ष
Giovanni Grazzi, MD, मुख्य अन्वेषक, Professor, Università degli Studi di Ferrara
अध्ययन केंद्रीय संपर्क
संपर्क: Giovanni Grazzi, Professor, +39 0535455963, [email protected]
1 1 देशों में अध्ययन स्थल

Ferrara

Center for Exercise Science and Sport, Ferrara, Ferrara, 44123, Italy
Giovanni Grazzi, Professor, संपर्क, +39 0535455963, [email protected]
Andrea Raisi, MSc, संपर्क, +39 0535455963, [email protected]
Giovanni Grazzi, Professor, मुख्य अन्वेषक
Gianni Mazzoni, Professor, उप-अन्‍वेषक
Simona Mandini, PhD, उप-अन्‍वेषक
Andrea Raisi, MSc, उप-अन्‍वेषक
Tommaso Piva, MSc, उप-अन्‍वेषक
Valentina Zerbini, MSc, उप-अन्‍वेषक
Sabrina Masotti, PhD, उप-अन्‍वेषक
भर्ती जारी